JNJohnson & Johnson JNJ · NYSE
$253.40 -0.20% (-$0.51)
- Market cap
- $611.9B
- Enterprise value
- $640.6B
- P/E
- 38.0x
- Forward P/E
- 21.8x
- PEG
- 0.3x
- P/S
- 6.2x
- P/FCF
- 32.7x
- EV/EBITDA
- 20.8x
- ROIC
- 14.7%
- Bruto marža
- 71.3%
- Neto marža
- 16.2%
- Dividend yield
- 2.08%
- Payout ratio
- 79.1%
- Neto dolg/EBITDA
- 0.9x
- Beta
- 0.24
- Free float
- 99.8%
O podjetju
Johnson & Johnson (JNJ) is a global pharmaceutical, medical, and consumer goods manufacturing company with a diverse portfolio of products. For over 130 years, they have been delivering innovative medicines, medical devices, and consumer products that improve people's lives worldwide. With a strong market position and a history of consistent dividend growth, Johnson & Johnson stock is attractive to conservative investors seeking stable and income-generating returns. Add JNJ stock to your watchlist on Bulios and stay informed about the latest news and innovations from this established company.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Joaquin Duato
Employees
141,700
Headquarters
New Brunswick
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke